Leukocyte Cell‐Derived Chemotaxin‐2: It's Role in Pathophysiology and Future in Clinical Medicine
Authors:
Open Access
- 23 May 2017
- journal article
- review article
- Published by Wiley in Clinical and Translational Science
- Vol. 10 (4) , 249-259
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- iTRAQ-based proteomics reveals novel biomarkers of osteoarthritisBiomarkers, 2013
- Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in miceJournal of Clinical Investigation, 2012
- Prokaryotic expression, purification, and refolding of leukocyte cell-derived chemotaxin 2 and its effect on gene expression of head kidney-derived macrophages of a teleost fish, ayu (Plecoglossus altivelis)Fish & Shellfish Immunology, 2011
- β‐catenin, cartilage, and osteoarthritisAnnals of the New York Academy of Sciences, 2010
- β-Catenin Regulates Vitamin C Biosynthesis and Cell Survival in Murine LiverJournal of Biological Chemistry, 2009
- Beta-Catenin Activation Promotes Liver Regeneration after Acetaminophen-Induced InjuryThe American Journal of Pathology, 2009
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- Deficiency of Mbd2 Attenuates Wnt SignalingMolecular and Cellular Biology, 2008
- A central role for JNK in obesity and insulin resistanceNature, 2002
- Molecular Cloning, Structural Characterization, and Chromosomal Mapping of the Human LECT2 GeneGenomics, 1998